Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 24.32
-0.84 (-3.34%)
May 12, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 11.47 billion as of May 12, 2026. Its market cap has increased by 20.21% in one year.
Market Cap
11.47B
Enterprise Value
9.86B
Revenue
1.42B
Ranking
n/a
PE Ratio
105.12
Stock Price
24.32
Market Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 11.47B, an increase of 1,780.19%. That is a compound annual growth rate of 15.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 11.09B | -3.49% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 13.01B |
| InventisBio | 13.00B |
| Hualan Biological Vaccine | 12.97B |
| Chongqing Genrix Biopharmaceutical | 11.39B |
| Pacific Shuanglin Bio-pharmacy | 11.31B |
| Chengdu Easton Biopharmaceuticals | 11.28B |
| HitGen | 10.98B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.25B |